Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

RLS Global

1997 FOUNDED
PUBLIC STATUS
1-10 EMPLOYEES
RLS STOCK SYMBOL
$0.70 SHARE PRICE (As of Tuesday Closing)
Description

RLS Global AB develops and sells biochemical products for the treatment of some of common diseases in wound and dental care.

Website
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Medicinaregatan 8B
  • 413 46 Goteborg
  • Sweden

+46 031-780 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore RLS Global’s full profile, request a free trial.

RLS Global Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.53 - $1.09 $41.3M $0.68 -$0.04 84.5K 59.2M

RLS Global Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 56,388 35,262 35,113 59,152
Revenue 307 301 273 336
EBITDA (2,333) (2,357) (2,188) (1,535)
Net Income (2,449) (2,516) (2,262) (1,606)
Total Assets 2,743 4,333 7,233 1,363
Total Debt 549
Public Fundamental Data provided by Morningstar, Inc. disclaimer